An impedance spectroscopy system for monitoring ischemic mucosal damage in hollow viscous organs comprises a sensor catheter and an impedance spectrometer for electrically driving the catheter to obtain a complex tissue impedance spectrum. Once the catheter is in place in one of a patient's hollow viscous organs, the impedance spectrometer obtains the complex impedance spectrum by causing two electrodes in the tip of the catheter to inject a current into the mucosal tissue at different frequencies, while two other electrodes measure the resulting voltages. A pattern recognition system is then used to analyze the complex impedance spectrum and to quantify the severity of the mucosal injury. Alternatively, the complex impedance spectrum can be appropriately plotted against the spectrum of normal tissue, allowing for a visual comparison by trained personnel.

Patent
   RE44667
Priority
Jul 19 2000
Filed
Apr 12 2007
Issued
Dec 24 2013
Expiry
Jul 18 2021

TERM.DISCL.
Assg.orig
Entity
Small
4
62
all paid
0. 20. A catheter comprising:
a. a plurality of electrodes separated by spacers, made of a relative non-conductor of electricity, wherein the spacers and electrodes are interconnected;
b. each electrode has at least one electrode through-bore and at least one passageway extending through the electrode;
c. the spacers have at least one spacer though-bore aligned with at least one electrode through-bore, and have passageways which are connected to passageways in the electrodes to form discrete channels through which leads attached to respective electrodes pass; and
d. whereby the leads are insulated and isolated from one another.
0. 21. A catheter comprising:
a plurality of electrodes each having an annular side surface, at least one electrode through-bore and at least one passageway extending through the electrodes;
at least one spacer made of a relative non-conductor of electricity, the at least one spacer connected to the electrodes and disposed to electrically isolate the electrodes from one another;
the at least one spacer including at least one spacer through-bore aligned with at least one electrode through-bore, and including at least one passageway connected to the at least one passageway in the electrodes; and
leads extending through the electrode and spacer passageways, the leads connected to corresponding electrodes.
0. 29. A catheter comprising:
a plurality of electrodes each having an annular sidewall, a through-bore and at least one passageway extending through the electrodes;
at least one spacer made of a relative non-conductor of electricity, the at least one spacer disposed to electrically isolate the electrodes from one another, the at least one spacer including a spacer through-bore connected to the electrode through-bore, and at least one passageway connected to the at least one passageway in the electrodes;
a projection extending though the electrode and spacer through-bores along a length of the catheter; and
leads extending along the length of the catheter through the electrode and spacer passageways, the leads connected to corresponding electrodes.
0. 17. A catheter comprising:
a. a tip having a rounded fore portion and a projection extending back from the fore portion;
b. a plurality of electrodes, each having an annular side surface;
c. at least one spacer, made of a relative non-conductor of electricity, having: an annular side surface; and a through-bore extending through the spacer, which is complementary in shape to the projection and mounted onto the projection;
d. a plurality of electrical leads respectively electrically connected to the plurality of electrodes; wherein:
i. the electrodes are spaced apart form one another by the at least one spacer being positioned therebetween; and
ii. the electrodes are connected to the at least one spacer; and
e. discrete passageways in the electrodes;
f. a passageway in the at least one spacer, wherein the spacer passageway connects with one of the passageways of the electrodes; and
g. an electrical lead extends separately through the connecting electrode and spacer passageways, whereby the lead is insulated and isolate.
0. 18. A catheter comprising:
a. a tip having a rounded fore portion and a projection extending back from the fore portion;
b. a plurality of electrodes, each having an annular side surface;
c. at least one of the electrodes has a through-bore, which is complementary in shape to the projection, and mounted onto the projection;
d. at least one spacer, made of a relative non-conductor of electricity, having an annular side surface;
e. a plurality of electrical leads respectively electrically connected to the plurality of electrodes; wherein:
i. the electrodes are spaced apart from one another by the at least one spacer being positioned therebetween; and
ii. the electrodes are connected to the at least one spacer; and
f. discrete passageways in the electrodes;
g. a passageway in the at least one spacer, wherein the spacer passageway connects with one of the passageways of the electrodes; and
h. an electrical lead extends separately through the connecting electrode and spacer passageways, whereby the lead is insulated and isolated.
0. 25. A catheter comprising:
a plurality of electrodes each having an annular side surface and at least one passageway extending through the electrodes;
at least one spacer made of a relative non-conductor of electricity, the at least one spacer connected to the electrodes and disposed to electrically isolate the electrodes from one another;
the at least one spacer including at least one passageway connected to the at least one passageway in the electrodes; and
leads extending through the electrode and spacer passageways, the leads connected to corresponding electrodes,
wherein each electrode includes a cylindrical central portion having an annular side surface and first and second cylindrical extensions extending from opposite ends of the cylindrical central portion, the first and second cylindrical extensions having a diameter smaller than the diameter of the cylindrical central portion, and
wherein each spacer includes a through-bore to connect to the electrode by fitting the cylindrical extensions of the electrode in the spacer through-bore such that the spacer abuts to the cylindrical central portions.
0. 12. A catheter for use in a system for monitoring mucosal damage in hollow viscous organs, the catheter comprising:
a. a tip having a rounded fore portion and a projection extending back from the fore portion;
b. a plurality of electrodes, each having an annular side surface;
c. at least one spacer, made of a relative non-conductor of electricity, having an annular side surface; and a through-bore extending through the spacer, which is complementary in shape to the projection, and mounted onto the projection;
d. a length of tubing suitable for insertion into hollow viscous organs;
e. a plurality of electrical leads respectively electrically connected to the plurality of electrodes; wherein:
i. the electrodes are spaced apart from one another by the at least one spacer being positioned therebetween; and
ii. the electrodes are connected to the at least one spacer; and
f. discrete passageways in the electrodes;
g. a passageway in the at least one spacer, wherein the spacer passageway connects with one of the passageways of the electrodes; and
h. an electrical lead extends separately through the connecting electrode and spacer passageways, whereby the lead is insulated and isolated.
0. 14. A catheter for use in a system for monitoring mucosal damage in hollow viscous organs, the catheter comprising:
a. a tip having a rounded fore portion and a projection extending back from the fore portion;
b. a plurality of electrodes, each having an annular side surface;
c. at least one of the electrodes has a through-bore, which is complementary in shape to the projection, and mounted onto the projection;
d. at least one space, made of a relative non-conductor of electricity, having an annular side surface;
e. a length of tubing suitable for insertion into hollow viscous organs;
f. a plurality of electrical leads respectively electrically connected to the plurality of electrodes; wherein:
i. the electrodes are spaced apart from one another by the at least one spacer being positioned therebetween; and
ii. the electrodes are connected to the at least one spacer; and
g. discrete passageways in the electrodes;
h. a passageway in the at least one spacer, wherein the spacer passageway connects with one of the passageways of the electrodes; and
i. an electrical lead extends separately through the connecting electrode and spacer passageways, whereby the lead is insulated and isolated.
0. 16. A catheter comprising:
a. a tip having a rounded fore portion and a projection extending back from the fore portion;
b. a plurality of electrodes each having: an annular side surface; and a through-bore extending through the electrode and complementary in shape to the projection;
c. a plurality of spacers, made of a relative non-conductor of electricity, each having: an annular side surface; and a through-bore extending through the spacer and complementary in shape to the projection;
d. a length of tubing suitable for insertion into hollow viscous organs;
e. a plurality of electrical leads respectively electrically connected to the plurality of electrodes; wherein:
i. the electrodes are positioned over the projection with the projection extending through the electrode through-bores, the electrodes being spaced apart from one another by respective spacers being positioned therebetween and over the projection with the projection extending through the spacer through-bores; and
ii. a rear portion of the projection lies inserted within the tubing, with the electrodes and at least one spacer being positioned between the rounded fore portion of the tip and an end of the tubing; and
f. a plurality of discrete passageways in the electrodes;
g. a plurality of discrete passageways in the spacers; and
h. the electrical leads extend separately through the connecting electrode passageways and spacer passageways, whereby the leads are insulated and isolated from one another.
0. 11. A catheter for use in a system for monitoring mucosal damage in hollow viscous organs, the catheter comprising:
a. a tip having a rounded fore portion and a projection extending back from the fore portion;
b. a plurality of electrodes each having: an annular side surface; and a through-bore extending through the electrode and complementary in shape to the projection;
c. a plurality of spacers, made of a relative non-conductor of electricity, each having: an annular side surface; and a through-bore extending through the spacer and complementary in shape to the projection;
d. a length of tubing suitable for insertion into hollow viscous organs;
e. a plurality of electrical leads respectively electrically connected to the plurality of electrodes; wherein:
i. the electrodes are positioned over the projection with the projection extending through the electrode through-bores, the said electrodes being spaced apart from one another by respective spacers being positioned therebetween and over the projection with the projection extending through the spacer through-bores; and
ii. a rear portion of the projection lies inside within the tubing, with the electrodes and at least one spacer being positioned between the rounded fore portion of the tip and an end of the tubing; and
f. a plurality of discrete passageways in the electrodes;
g. a plurality of discrete passageways in the spacers; and
h. the electrical leads extend separately through connecting electrode passageways and spacer passageways, whereby the leads are insulated and isolated form one another.
0. 1. A catheter for use in a system for monitoring mucosal damage in hollow viscous organs, said catheter comprising:
a. a length of tubing suitable for insertion into hollow viscous organs;
b. a plurality of electrodes disposed proximate a distal end of the tubing; and
c. a plurality of electrical leads respectively electrically connected to the plurality of electrodes and extending through the tubing to a proximal end thereof;
wherein:
d. the electrodes each comprise: a cylindrical central portion having an annular side wall and a diameter generally equal to an outer diameter of the tubing; first and second cylindrical extensions attached to a top and a bottom of the cylindrical central portion, respectively, and coaxial therewith, said first and second cylindrical extensions having a diameter smaller than the diameter of the cylindrical central portion; and an axial bore extending through the cylindrical central portion and first and second cylindrical extensions; and
e. the electrodes are spaced apart from one another by annular spacers positioned over the cylindrical extensions and abutting the cylindrical central portions.
0. 2. The catheter of claim 1 further comprising a fill extending through the spacers and axial bores of the electrodes.
0. 3. A catheter for use in a system for monitoring mucosal damage in hollow viscous organs, said catheter comprising:
a. a length of tubing suitable for insertion into hollow viscous organs;
b. a plurality of electrodes disposed proximate a distal end of the tubing; and
c. a plurality of electrical leads respectively electrically connected to the plurality of electrodes and extending through the tubing to a proximal end thereof;
wherein:
d. the electrodes each comprise: a cylindrical central portion having an annular side wall and a diameter generally equal to an outer diameter of the tubing; first and second cylindrical extensions attached to a top and a bottom of the cylindrical central portion, respectively, and coaxial therewith, said first and second cylindrical extensions having a diameter smaller than the diameter of the cylindrical central portion; and an axial bore extending through the cylindrical central portion and first and second cylindrical extensions; and
e. the electrodes are spaced apart from one another by annular spacers positioned over the cylindrical extensions and abutting the cylindrical central portions, wherein:
i. the spacers each have two annular, inwardly-facing shoulders spaced back from the ends of the spacers; and
f. the cylindrical extensions of the electrodes each have an annular lip facing towards the cylindrical central portions, wherein the cylindrical extensions are dimensioned to fit within the spacers such that the lips abut the shoulders, locking the electrodes to the spacers.
0. 4. The catheter of claim 3 further comprising a fill extending through the spacers and axial bores of the electrodes.
0. 5. A catheter for use in a system for monitoring mucosal damage in hollow viscous organs, said catheter comprising:
a. a tip having a rounded fore portion and a projection extending back from the fore portion;
b. a plurality of electrodes each having: an annular side surface; and a through-bore extending through the electrode and complementary in shape to the projection;
c. at least one spacer having: an annular side surface; and a through-bore extending through the spacer and complementary in shape to the projection;
d. a length of tubing suitable for insertion into hollow viscous organs; and
e. a plurality of electrical leads respectively electrically connected to the plurality of electrodes; wherein:
f. the electrodes are positioned over the projection with the projection extending through the electrode through-bores, said electrodes being spaced apart from one another by the at least one spacer being positioned therebetween and over the projection with the projection extending through the spacer through-bore; and
g. a rear portion of the projection lies inserted within the tubing, with the electrodes and at least one spacer being positioned between the rounded fore portion of the tip and an end of the tubing.
0. 6. The catheter of claim 5 wherein the through-bores and the projection are both V-shaped.
0. 7. The catheter of claim 5 wherein the through-bores and the projection both have a rounded trough shape.
0. 8. The catheter of claim 5 wherein:
a. each electrode further comprises a passageway extending through the electrode;
b. the at least one spacer further comprises a passageway extending through the spacer; and
c. the electrical leads extend through the electrode and spacer passageways.
0. 9. The catheter of claim 5 wherein there are four electrodes and three spacers.
0. 10. In a catheter for use in a system for monitoring mucosal damage in hollow viscous organs, wherein the catheter includes a length of tubing suitable for insertion into hollow viscous organs, a plurality of electrodes disposed proximate a distal end of the tubing, the improvement comprising:
a. a plurality of electrical leads respectively electrically connected to the plurality of electrodes and extending through the tubing to a proximal end thereof;
b. a plurality of annular spacers adapted in size and shape to be mounted on the catheter, and,
c. means for interconnecting adjacent spaced apart pairs of the spacers with electrodes snap locking into the pairs, wherein:
i. the interconnecting electrodes each have cylindrical central portions with two annular side walls and a diameter generally equal to an outer diameter of the tubing sections: first and second cylindrical extensions attached to a top and a bottom of the cylindrical central portion, respectively, and coaxial therewith, said first and second cylindrical extensions having a diameter smaller than the diameter of the cylindrical central portion; and an axial bore extending through the cylindrical central portion and first and second cylindrical extensions; and
ii. the extensions fit into through-bores of the spacers.
0. 13. The catheter of claim 12 wherein each electrode has a through-bore.
0. 15. The catheter of claim 14 wherein the at least one spacer has a through-bore.
0. 19. The catheter of claim 18 wherein the at least one spacer has a through-bore.
0. 22. The catheter of claim 21 further comprising a projection extending through the electrode and spacer though-bores.
0. 23. The catheter of claim 22 where the electrode and spacer through-bore have a shape complementary to the shape of the projection.
0. 24. The catheter of claim 22 further comprising a tip extending from the projection to a rounded fore portion.
0. 26. The catheter of claim 25 where:
the spacers each include at least on annular, inwardly-facing shoulders spaced back from the ends of the spacers; and
the cylindrical extensions of the electrodes each include an annular lip facing the cylindrical central portions, the cylindrical extensions dimensioned to fit within the spacers such that the lips abut the shoulders to lock the electrodes to the spacers.
0. 27. The catheter of claim 25 where the electrodes and spacers include aligned through-bores, the catheter further comprising:
a projection extending through the electrode and spacer through-bores along a length of the catheter; and
a length of tubing enclosing the projection through the length of the catheter and extending to cover the cylindrical extension of the first of the plurality of electrodes, the diameter of the tubing being substantially the same as tote diameter of the cylindrical central portion.
0. 28. The catheter of claim 21 where the leads are insulated and isolated from one another.
0. 30. The catheter of claim 29 further comprising:
a length of tubing enclosing the projection and the leads along the length of the catheter and extending to an end of the tubing abutting the first of the plurality of electrodes.
0. 31. The catheter of claim 29 further comprising a tip extending from the projection to a rounded fore portion.
0. 32. The catheter of claim 29 where the leads are insulated and isolated from one another.

X=Z sin  Eq. 2.
Analysis of these plots shows that normal tissue spectra have a characteristic shape or pattern. According to the Cole-Cole electric model of biological tissues, this shape is the arc of a circle when plotted in the complex plane. However, if tissue is damaged after an extended period of ischemia, the spectra of the damaged tissue loses this characteristic shape. In fact, when plotted in the complex plane, the spectra of the damaged tissue become sigmoid- or S-shaped, deviating significantly from the normal tissue spectra.

FIGS. 8A-11C show averaged experimental data obtained in the small intestine of a group of test subjects subjected to a period of intestinal ischemia followed by a period of reperfusion (restored blood flow), in comparison to a group of test subjects in which normal perfusion and oxygenation was maintained. The data is presented in both the frequency plots and in the complex plane. For the Nyquist plots (complex plane), the data has been normalized so that the shapes of the curves can be more easily compared, e.g., the point at the highest measurement frequency (300 KHz) has an adimensional impedance of 1 and a phase angle of 0.

FIGS. 8A-8C show the impedance spectra of intestine with less than ten minutes of reduced blood flow, wherein the intestine is already ischemic, with associated rising acidity. In particular, FIGS. 8A and 8B show the average amplitude and phase impedance spectra, respectively, of both normal intestine and the intestine subjected to reduced blood flow, while FIG. 8C shows the normalized Nyquist plot of the normal and ischemic intestinal tissue. As can be seen, although the intestine with reduced blood flow is ischemic, the tissue is not yet damaged, and the spectra are not easily distinguishable from the spectra of the normally perfused intestines. Note that the spectra contain some noise, but resemble the circular arc predicted by the Cole-Cole model.

FIGS. 9A and 9B show the average amplitude and phase impedance spectra, respectively, of both normal intestine and intestine after 1.5 hours of severe ischemia, while FIG. 9C shows the normalized Nyquist plot of the normal and ischemic intestinal tissue. Here, the ischemic tissue has suffered moderate damage, and the spectra have become clearly distinguishable B the ischemic tissue spectra have lost their circular shape and have taken on a sigmoidal shape with several inflection points.

FIGS. 10A-10C show similar plots for normal intestines and intestines after two hours of severe ischemia. By now, the damage is even more severe, and the spectra have become even more distorted.

FIGS. 11A-11C show the spectra of normal intestines and intestines after an hour of ischemia followed by 1.5 hours of reperfusion. After an hour of ischemia, the tissue has suffered some damage. However, after being reperfused, most of this damage has been reversed, and the spectra of the damaged tissue have largely regained their characteristic shape, although they are still somewhat abnormal and are still moderately distinguishable from the spectra of the normal tissue.

As should be appreciated, a plot or graph of the complex impedance spectrum of potentially damaged tissue versus the spectrum of normal tissue, e.g., as shown in FIGS. 8A-11C, can be used by appropriately-trained personnel to determine the level of damage due to ischemia, by way of a visual comparison. Accordingly, the signal processing device 22 may be configured to graph or plot the spectrum for visual analysis, accordingly the general guidelines given above, on a screen or monitor, or by way of a print-out.

Alternatively, the signal processing device 22 can be configured to automatically determine tissue damage, by way of the pattern recognition system or other standard signal processing techniques, such as filtering, or smoothing and extracting inflection points by analysis of derivatives. Another alternative is the use of principal component decomposition or any other method of extracting a characteristic vector describing the shape of the spectrum. Such a characteristic vector can then be analyzed by a classifying or pattern recognition algorithm to provide a score in a predetermined tissue damage scale. Such an algorithm can use one of many standard techniques for classification and/or pattern recognition, such as Bayesian statistics, neural networks, fuzzy logic, statistical classifiers, expert systems, or any combination of these. Further detail regarding a pattern recognition system suitable for use or adaptation for use in the present invention can be found in U.S. Pat. No. 5,807,272 to Kun et al., previously incorporated by reference.

Although the catheters of the present invention have been illustrated as having Ag/AgCl electrodes, one of ordinary skill in the art will appreciate that other types of electrodes could be used instead without departing from the spirit and scope of the invention.

Although the electrodes and spacers of the fourth embodiment of the catheter have been illustrated as having separate passageways and through-bores, one of ordinary skill in the art will appreciate that the passageways and through-bores could be connected, i.e., they do not have to be separate openings, as long as there is a space for the leads.

Since certain changes may be made in the above described impedance spectroscopy system and catheter for ischemic mucosal damage monitoring in hollow viscous organs, without departing from the spirit and scope of the invention herein involved, it is intended that all of the subject matter of the above description or shown in the accompanying drawings shall be interpreted merely as examples illustrating the inventive concept herein and shall not be construed as limiting the invention.

Rock, Emilio Sacristan

Patent Priority Assignee Title
10251569, Jun 28 2012 Volcano Corporation Connection structures for intravascular devices and associated systems and methods
11458300, Dec 28 2018 Heraeus Medical Components LLC Overmolded segmented electrode
9655531, Jun 28 2012 Volcano Corporation Connection structures for intravascular devices and associated systems and methods
9750417, Jun 28 2012 Volcano Corporation Connection structures for intravascular devices and associated systems and methods
Patent Priority Assignee Title
2008295,
2018080,
2184511,
2729211,
3340867,
3480003,
4146254, Mar 31 1976 NEWTECH COMPANY, A CORP OF MI Coupler for tubing
4224949, Nov 17 1977 Cornell Research Foundation, Inc. Method and electrical resistance probe for detection of estrus in bovine
4437474, Jul 16 1982 Pacesetter, Inc Method for making multiconductor coil and the coil made thereby
4476872, Mar 07 1980 The Kendall Company Esophageal probe with disposable cover
4498481, Sep 28 1982 Estrus cycle monitoring system
4559951, Nov 29 1982 Cardiac Pacemakers, Inc. Catheter assembly
4602809, Nov 21 1984 Hughes Missile Systems Company Miniature O-ringless gas line isolator
4690152, Oct 23 1985 American Mediscan, Inc. Apparatus for epithelial tissue impedance measurements
4729385, Oct 23 1985 American Mediscan, Inc. Probe and method of use for detecting abnormal tissues
4836214, Dec 01 1986 Cardiodynamics International Corporation Esophageal electrode array for electrical bioimpedance measurement
4852580, Sep 17 1986 Axiom Medical, Inc. Catheter for measuring bioimpedance
4960133, Nov 21 1988 BRUNSWICK BIOMEDICAL TECHNOLOGIES, INC , A MA CORP Esophageal electrode
5069223, Feb 14 1990 Georgetown University Method of evaluating tissue changes resulting from therapeutic hyperthermia
5074827, Aug 28 1990 AMERICAN LONGWALL FACE CONVEYORS, INC Reversible chain conveyor sprocket assembly
5109851, Feb 06 1989 MARMON HOLDING, INC Multiple electrode affixable sheet
5158083, Oct 23 1989 Instrumentarium Corp Miniature pCO2 probe for in vivo biomedical applications
5280429, Apr 30 1991 XITRON TECHNOLOGIES A CA CORPORATION Method and apparatus for displaying multi-frequency bio-impedance
5282840, Mar 26 1992 Medtronic, Inc. Multiple frequency impedance measurement system
5304219, Jun 14 1991 Pacesetter, Inc Multipolar in-line proximal connector assembly for an implantable stimulation device
5306052, Dec 15 1992 ROBINSON, ERIC Tubing union with a torque transfer fitting
5335668, Apr 30 1993 Medical Scientific, Inc. Diagnostic impedance measuring system for an insufflation needle
5381790, Jun 23 1993 UNI-CATH INC Electrophysiology apparatus
5423320, Apr 20 1993 INSTRUMENTARIUM Air tonometry method and apparatus for measuring intraluminal gastrointestinal pCO2 and pO2
5438985, Jan 25 1993 Medtronic, Inc Ambulatory recording of the presence and activity of substances in gastro-intestinal compartments
5454377, Oct 08 1993 Tyco Submarine Systems Ltd Method for measuring the myocardial electrical impedance spectrum
5456254, Feb 15 1991 Cardiac Pathways Corporation Flexible strip assembly having insulating layer with conductive pads exposed through insulating layer and device utilizing the same
5477854, Sep 16 1993 Medtronic, Inc System and method to monitor gastrointestinal Helicobacter pylori infection
5479935, Oct 21 1993 Medtronic, Inc Ambulatory reflux monitoring system
5585402, Dec 23 1992 Glaxo Wellcome Inc Nitric oxide synthase inhibitors
5633801, Oct 11 1995 Fluke Corporation Pulse-based impedance measurement instrument
5657759, May 13 1993 Medtronic, Inc Measurement of gastric emptying and gastrointestinal output
5771894, Jun 05 1995 Vanderbilt University Non invasive identification of intestinal ischemia from measurement of basic electrical rhythm of intestinal smooth muscle electrical activity using a magnetometer
5788631, Mar 22 1982 Instrumentarium Corporation Hollow viscus and solid organ tonometry
5807272, Oct 30 1996 WORCESTER POLYTECHNIC Impedance spectroscopy system for ischemia monitoring and detection
5810742, Oct 24 1994 MIRABEL MEDICAL SYSTEMS LTD Tissue characterization based on impedance images and on impedance measurements
5833625, Oct 21 1993 Medtronic, Inc Ambulatory reflux monitoring system
5848965, Jan 24 1994 Medtronic, Inc Method and a system for the determination of pH and other fluid parameters utilizing a metal monocrystalline electrode
5922701, May 01 1992 UTAH, UNIVERSITY OF; University of Utah Research Foundation Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
5981590, Mar 17 1997 ProBiotix, Inc.; PROBIOTIX, INC Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage
5991650, Dec 16 1993 EP Technologies, Inc. Surface coatings for catheters, direct contacting diagnostic and therapeutic devices
6010453, Mar 22 1982 Instrumentarium Corporation Tonometric catheter combination
6017881, Apr 22 1994 XOMA Corporation Method of treating conditions associated with intestinal ischemia/reperfusion
6032061, Feb 20 1997 Boston Scientific Corporation Catheter carrying an electrode and methods of assembly
6055452, Oct 24 1994 MIRABEL MEDICAL SYSTEMS LTD Tissue characterization based on impedance images and on impedance measurements
6882879, Jul 19 2000 CRITICAL PERFUSION, INC Impedance spectroscopy system and catheter for ischemic mucosal damage monitoring in hollow viscous organs
6965795, Jul 19 2000 CRITICAL PERFUSION, INC Impedance spectroscopy method for monitoring ischemic mucosal damage in hollow viscous organs
7650183, Jul 19 2000 CRITICAL PERFUSION, INC Impedance spectroscopy system for ischemic mucosal damage monitoring in hollow viscous organs
20020013537,
20030053416,
20050070769,
20060015035,
EP797950,
RE30101, Jun 23 1975 Regents of the University of Minnesota Impedance plethysmograph
WO8200581,
WO8204182,
WO9848692,
////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Apr 12 2007Critical Perfusion, Inc.(assignment on the face of the patent)
Dec 03 2007INNOVAMEDICA S A DE C V INNOVAMEDICA S A P I DE C V CHANGE OF NAME SEE DOCUMENT FOR DETAILS 0232820534 pdf
Jun 09 2008SACRISTAN ROCK, EMILIOINNOVAMEDICA S A DE C V ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0210710369 pdf
Nov 11 2008INNOVAMEDICA S A P I DE C V CRITICAL PERFUSION, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0232920045 pdf
Date Maintenance Fee Events
Jul 28 2016ASPN: Payor Number Assigned.
Oct 19 2016M2553: Payment of Maintenance Fee, 12th Yr, Small Entity.


Date Maintenance Schedule
Dec 24 20164 years fee payment window open
Jun 24 20176 months grace period start (w surcharge)
Dec 24 2017patent expiry (for year 4)
Dec 24 20192 years to revive unintentionally abandoned end. (for year 4)
Dec 24 20208 years fee payment window open
Jun 24 20216 months grace period start (w surcharge)
Dec 24 2021patent expiry (for year 8)
Dec 24 20232 years to revive unintentionally abandoned end. (for year 8)
Dec 24 202412 years fee payment window open
Jun 24 20256 months grace period start (w surcharge)
Dec 24 2025patent expiry (for year 12)
Dec 24 20272 years to revive unintentionally abandoned end. (for year 12)